[go: up one dir, main page]

NO934477L - PEG hydrazone and PEG oxime-binding reagents and protein derivatives thereof - Google Patents

PEG hydrazone and PEG oxime-binding reagents and protein derivatives thereof

Info

Publication number
NO934477L
NO934477L NO934477A NO934477A NO934477L NO 934477 L NO934477 L NO 934477L NO 934477 A NO934477 A NO 934477A NO 934477 A NO934477 A NO 934477A NO 934477 L NO934477 L NO 934477L
Authority
NO
Norway
Prior art keywords
peg
water
polymeric reagents
soluble polymeric
hydrazone
Prior art date
Application number
NO934477A
Other languages
Norwegian (no)
Other versions
NO934477D0 (en
Inventor
David E Wright
Original Assignee
Ortho Pharma Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Pharma Corp filed Critical Ortho Pharma Corp
Publication of NO934477D0 publication Critical patent/NO934477D0/en
Publication of NO934477L publication Critical patent/NO934477L/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C08G65/333—Polymers modified by chemical after-treatment with organic compounds containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/04—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers only
    • C08G65/06—Cyclic ethers having no atoms other than carbon and hydrogen outside the ring
    • C08G65/16—Cyclic ethers having four or more ring atoms
    • C08G65/20—Tetrahydrofuran

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Other Resins Obtained By Reactions Not Involving Carbon-To-Carbon Unsaturated Bonds (AREA)

Abstract

Det blir beskrevet fremgangsmåter og forbindelser for modifisering av polypeptider med PEG eller andre vannoppløsellge organiske polymerer. Nye vannoppløselige polymerreagenser blir fremskaffet. De vannoppløsellge polymerreagensene omfatter hydrazln, hydrazinkarboksylat, semlkarbazld, tiosemikarbazid, karbonsyredlhydrazld, karbazid, tiokarbazid og arylhydrazidderivater så vel som oksylaminderivater av vannoppløsellge organiske polymerer, slik som poly- etylenglykol, polypropylenglykol, polyoksyetylert polyol, heparln, heparlnfragmenter, dekstran, poly- sakkarider, polyaminosyrer og polyvlnylalkohol. Det ble også fremskaffet aktuelle peptider som er derlvatisert ved foreliggende vannoppløselige polymer- reagenser . Det ble også beskrevet sett for modifisering av polypeptider med foreliggende vannoppløselige polymer- reagenser .Methods and compounds for modifying polypeptides with PEG or other water-soluble organic polymers are described. New water-soluble polymeric reagents are provided. The water-soluble polymeric reagents include hydrazine, hydrazine carboxylate, semicarbazide, thiosemicarbazide, carboxylic acid dihydrazide, carbazide, thiocarbazide and arylhydrazide derivatives as well as oxyamine paraffinic acid, polyethylene glycol, polyethylene glycol, and polyvinyl alcohol. Relevant peptides were also obtained which are derivatized by the present water-soluble polymeric reagents. Kits were also described for modifying polypeptides with the present water-soluble polymeric reagents.

NO934477A 1992-12-09 1993-12-08 PEG hydrazone and PEG oxime-binding reagents and protein derivatives thereof NO934477L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US98773992A 1992-12-09 1992-12-09
US4505293A 1993-04-07 1993-04-07

Publications (2)

Publication Number Publication Date
NO934477D0 NO934477D0 (en) 1993-12-08
NO934477L true NO934477L (en) 1994-06-10

Family

ID=26722325

Family Applications (1)

Application Number Title Priority Date Filing Date
NO934477A NO934477L (en) 1992-12-09 1993-12-08 PEG hydrazone and PEG oxime-binding reagents and protein derivatives thereof

Country Status (5)

Country Link
JP (1) JPH07196925A (en)
KR (1) KR100254650B1 (en)
AU (1) AU5238393A (en)
FI (1) FI935485L (en)
NO (1) NO934477L (en)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586398B1 (en) * 2000-04-07 2003-07-01 Amgen, Inc. Chemically modified novel erythropoietin stimulating protein compositions and methods
AU2001290312A1 (en) * 2000-10-16 2002-04-29 Chugai Seiyaku Kabushiki Kaisha Peg-modified erythropoietin
US7173003B2 (en) 2001-10-10 2007-02-06 Neose Technologies, Inc. Granulocyte colony stimulating factor: remodeling and glycoconjugation of G-CSF
US7214660B2 (en) 2001-10-10 2007-05-08 Neose Technologies, Inc. Erythropoietin: remodeling and glycoconjugation of erythropoietin
US7247609B2 (en) 2001-12-18 2007-07-24 Universitat Zurich Growth factor modified protein matrices for tissue engineering
US20050148763A1 (en) * 2002-02-01 2005-07-07 Chugai Seiyaku Kabushiki Kaisha Peg-binding pth or peg-binding pth derivative
DE10209821A1 (en) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Coupling of proteins to a modified polysaccharide
DE10209822A1 (en) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Coupling of low molecular weight substances to a modified polysaccharide
EP1400533A1 (en) * 2002-09-11 2004-03-24 Fresenius Kabi Deutschland GmbH HASylated polypeptides, especially HASylated erythropoietin
MXPA05002591A (en) * 2002-09-11 2005-09-20 Fresenius Kabi Gmbh Hydroxyalkyl starch derivatives.
EP1615945B1 (en) 2003-04-09 2011-09-28 BioGeneriX AG Glycopegylation methods and proteins/peptides produced by the methods
WO2005012484A2 (en) 2003-07-25 2005-02-10 Neose Technologies, Inc. Antibody-toxin conjugates
WO2005014655A2 (en) * 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
US20080305992A1 (en) 2003-11-24 2008-12-11 Neose Technologies, Inc. Glycopegylated erythropoietin
JP5191729B2 (en) 2004-03-11 2013-05-08 フレゼニウス・カビ・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Conjugates of hydroxyalkyl starch and protein produced by reductive amination
EP1771066A2 (en) 2004-07-13 2007-04-11 Neose Technologies, Inc. Branched peg remodeling and glycosylation of glucagon-like peptide-1 glp-1
SI2586456T1 (en) 2004-10-29 2016-05-31 Ratiopharm Gmbh Remodeling and glycopegylation of fibroblast growth factor (FGF)
SG160437A1 (en) * 2004-12-22 2010-04-29 Ambrx Inc Modified human growth hormone
NZ556436A (en) 2005-01-10 2010-11-26 Biogenerix Ag Glycopegylated granulocyte colony stimulating factor
US9187546B2 (en) 2005-04-08 2015-11-17 Novo Nordisk A/S Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
US20070105755A1 (en) 2005-10-26 2007-05-10 Neose Technologies, Inc. One pot desialylation and glycopegylation of therapeutic peptides
US20090048440A1 (en) 2005-11-03 2009-02-19 Neose Technologies, Inc. Nucleotide Sugar Purification Using Membranes
US20080242607A1 (en) 2006-07-21 2008-10-02 Neose Technologies, Inc. Glycosylation of peptides via o-linked glycosylation sequences
ES2531934T3 (en) * 2006-09-01 2015-03-20 Novo Nordisk Health Care Ag Modified glycoproteins
US20100075375A1 (en) 2006-10-03 2010-03-25 Novo Nordisk A/S Methods for the purification of polypeptide conjugates
KR20100016160A (en) 2007-04-03 2010-02-12 바이오제너릭스 에이지 Methods of treatment using glycopegylated g-csf
JP5876649B2 (en) 2007-06-12 2016-03-02 ラツィオファルム ゲーエムベーハーｒａｔｉｏｐｈａｒｍ ＧｍｂＨ Improved process for producing nucleotide sugars
WO2009083544A2 (en) 2007-12-28 2009-07-09 Kuros Biosurgery Ag Pdgf fusion proteins incorporated into fibrin foams
CN101965200B (en) 2008-02-27 2013-06-19 诺沃-诺迪斯克有限公司 Conjugated factor VIII molecules
EP2275202A1 (en) 2008-03-13 2011-01-19 Ajinomoto Co., Inc. Carbonyl compound remover
JP5418360B2 (en) 2009-03-27 2014-02-19 日油株式会社 Method for producing polyoxyalkylene derivative
SG178141A1 (en) * 2009-07-27 2012-03-29 Baxter Int Blood coagulation protein conjugates
EP2459226B1 (en) * 2009-07-27 2016-06-29 Lipoxen Technologies Limited Glycopolysialylation of proteins other than blood coagulation proteins
PL2459224T3 (en) 2009-07-27 2017-08-31 Baxalta GmbH Blood coagulation protein conjugates

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1676992A (en) * 1991-03-18 1992-10-21 Enzon, Inc. Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers

Also Published As

Publication number Publication date
FI935485A0 (en) 1993-12-08
AU5238393A (en) 1994-06-23
KR940014430A (en) 1994-07-18
FI935485A7 (en) 1994-06-10
KR100254650B1 (en) 2000-05-01
NO934477D0 (en) 1993-12-08
FI935485L (en) 1994-06-10
JPH07196925A (en) 1995-08-01

Similar Documents

Publication Publication Date Title
NO934477L (en) PEG hydrazone and PEG oxime-binding reagents and protein derivatives thereof
DE69431932D1 (en) Oligopeptides with fungicidal activity
AU6055894A (en) Benzofuranyl- and -thiophenyl-alkanecarboxyclic acid derivatives
IS3834A (en) Method of adding water-soluble material
EP0721943A4 (en) AZOL DERIVATIVES AND PHARMACEUTICAL PREPARATIONS
NO20020758D0 (en) N <o> 6 </o> heterocyclic substituted adenosine derivatives
CA2157793A1 (en) Macromolecular Microparticles and Methods of Production
DE69632546D1 (en) Whether protein derivatives with extended half-life
EP0196112A3 (en) Aqueous high solids coating compositions
DE69113694D1 (en) Curable composition containing a crystallizable polymer.
FI101376B1 (en) Process for the preparation of 3-benzylamino-2-phenylpiperidine derivatives
FI90345C (en) Method for controlling epimeric distribution in the preparation of 16,17-acetals of pregnane derivatives
FI810029L (en) FRAMSTAELLNING AV HYDROXIDFOERENINGAR GENOM ELEKTROKEMISK REDUKTION
NO176880C (en) Analogous Process for Preparing Therapeutically Active Pyrimidinylpiperazinylalkylazole Derivatives
GB1274501A (en) Cationic monoazo dyestuffs
ES2121554A1 (en) Process for obtaining 14-hydroxymorphines by the photo- oxidation of morphine alkaloids with an alkoxydiene system in the C ring
DE69317122D1 (en) METHOD FOR PRODUCING TRIAZOLONE DERIVATIVES
ATA4682003A (en) Runge
GB992962A (en) Process for the manufacture of peptide derivatives
AU9462298A (en) Process for producing 3-cephem compounds
GB1338834A (en) Substituted furancarboxylic acid cycloalkylamide
SE8005599L (en) SET TO MAKE AN ANTIBIOTIC
DK0595164T3 (en) 4-Heterocyclophenyl-substituted dihydropyridines
ATE166654T1 (en) USE OF HALOGENATED BETA-LACTAMS FOR PRODUCING 3-HYDROXYCEPHEM DERIVATIVES
Berthet et al. Oxa–diketopiperazines: Access and Conformational Analysis of Potential Turn Inducers